Evidence map›Paper›PMID 36114005›Full record

ArticleLife science alliance2022

RSC and GRFs confer promoter directionality by restricting divergent noncoding transcription.

Andrew Ck Wu, Claudia Vivori, Harshil Patel, Theodora Sideri, Fabien Moretto, Folkert J van Werven

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Molecular models of bidirectional promoter regulation.Current opinion in structural biology · 2024
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Andrew Ck WuCell Fate and Gene Regulation Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0002-2429-2496
Claudia VivoriCell Fate and Gene Regulation Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0001-7008-0593
Harshil PatelBioinformatics and Biostatistics, The Francis Crick Institute, London, UK.ORCID 0000-0003-2707-7940
Theodora SideriCell Fate and Gene Regulation Laboratory, The Francis Crick Institute, London, UK.
Fabien MorettoCell Fate and Gene Regulation Laboratory, The Francis Crick Institute, London, UK.
Folkert J van WervenCell Fate and Gene Regulation Laboratory, The Francis Crick Institute, London, UK folkert.vanwerven@crick.ac.uk.ORCID 0000-0002-6685-2084
The Francis Crick Institute · GB

Funding

Cancer Research UKMedical Research CouncilWellcome Trust FC001203
6 · The paper itself

Abstract

The directionality of gene promoters-the ratio of protein-coding over divergent noncoding transcription-is highly variable. How promoter directionality is controlled remains poorly understood. Here, we show that the chromatin remodelling complex RSC and general regulatory factors (GRFs) dictate promoter directionality by attenuating divergent transcription relative to protein-coding transcription. At gene promoters that are highly directional, depletion of RSC leads to a relative increase in divergent noncoding transcription and thus to a decrease in promoter directionality. We find that RSC has a modest effect on nucleosome positioning upstream in promoters at the sites of divergent transcription. These promoters are also enriched for the binding of GRFs such as Reb1 and Abf1. Ectopic targeting of divergent transcription initiation sites with GRFs or the dCas9 DNA-binding protein suppresses divergent transcription. Our data suggest that RSC and GRFs play a pervasive role in limiting divergent transcription relative to coding direction transcription. We propose that any DNA-binding factor, when stably associated with cryptic transcription start sites, forms a barrier which represses divergent transcription, thereby promoting promoter directionality.

Indexed as

NucleosomesTranscription, GeneticDNADNA-Binding ProteinsPromoter Regions, GeneticDNADNA-Binding ProteinsNucleosomes

Identifiers

PMID36114005
PMCPMC9481977
OpenAlexW4296078464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.